Stay updated on Lenva+Pembro Combo in Cancers: Clinical Trial
Sign up to get notified when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.

Latest updates to the Lenva+Pembro Combo in Cancers: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has removed the estimated timestamps for when results were first posted and last updated, which may affect users' understanding of the timeliness of the information provided.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to include new results and details regarding the EPOC 1706 study on advanced gastric cancer, including updated response rates and survival metrics. Notably, the study now specifies the administration protocol for Pembrolizumab and includes new reporting dates for results.SummaryDifference74%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Lenva+Pembro Combo in Cancers: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.